JAK2 and essential thrombocythemia: In addition, mutations in exon 12 of JAK2 are identified in PV patients with or withoutJAK2-V617F mutation[7, 8], and W515L/K mutations in MPL gene are detected in ET and PMF patients with or without JAK2-V617F mutation[9, 10].